Circulating Metabolites as Biomarkers of Disease in Patients with Mesial Temporal Lobe Epilepsy

Circulating Metabolites as Biomarkers of Disease in Patients with Mesial Temporal Lobe Epilepsy

A major challenge in the clinical management of patients with mesial temporal lobe epilepsy (MTLE) is identifying those who do not respond to antiseizure medication (ASM), allowing for the timely pursuit of alternative treatments such as epilepsy surgery. Here, we investigated changes in plasma meta...

Full description

Bibliographic Details
Main Authors: Alexandre B. Godoi, Amanda M. do Canto, Amanda Donatti, Douglas C. Rosa, Danielle C. F. Bruno, Marina K. Alvim, Clarissa L. Yasuda, Lucas G. Martins, Melissa Quintero, Ljubica Tasic, Fernando Cendes, Iscia Lopes-Cendes
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Metabolites
Subjects:
metabolomics
antiseizure medication
<sup>1</sup>H Nuclear Magnetic Resonance
focal epilepsy
response to treatment
Online Access:https://www.mdpi.com/2218-1989/12/5/446

Internet

https://www.mdpi.com/2218-1989/12/5/446

Similar Items